KBC Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,155
Closed -$930K 1863
2025
Q4
$930K Sell
9,155
-4,367
-32% -$351K ﹤0.01% 681
2025
Q3
$740K Sell
13,522
-295
-2% -$14.7K ﹤0.01% 686
2025
Q2
$734K Sell
13,817
-13,925
-50% -$707K ﹤0.01% 677
2025
Q1
$1.2M Hold
27,742
﹤0.01% 652
2024
Q4
$1.56M Buy
27,742
+490
+2% +$30.5K ﹤0.01% 726
2024
Q3
$1.86M Buy
27,252
+5,368
+25% +$303K 0.01% 627
2024
Q2
$924K Hold
21,884
﹤0.01% 673
2024
Q1
$1.51M Hold
21,884
﹤0.01% 620
2023
Q4
$1.62M Sell
21,884
-21,199
-49% -$1.39M 0.01% 635
2023
Q3
$2.94M Buy
43,083
+5,950
+16% +$505K 0.01% 529
2023
Q2
$3.49M Sell
37,133
-63,979
-63% -$4.99M 0.01% 512
2023
Q1
$6.86M Buy
101,112
+49,494
+96% +$3.18M 0.03% 426
2022
Q4
$2.56M Sell
51,618
-165,160
-76% -$6.75M 0.01% 563
2022
Q3
$7.04M Sell
216,778
-25,668
-11% -$1.06M 0.04% 341
2022
Q2
$9.55M Sell
242,446
-332,884
-58% -$17.8M 0.05% 304
2022
Q1
$40.2M Buy
575,330
+83,122
+17% +$6.08M 0.16% 157
2021
Q4
$38.3M Buy
492,208
+315,078
+178% +$27.8M 0.13% 182
2021
Q3
$16.9M Buy
177,130
+119,070
+205% +$12.6M 0.06% 282
2021
Q2
$7.22M Sell
58,060
-5,754
-9% -$687K 0.01% 544
2021
Q1
$8.41M Buy
63,814
+25,488
+67% +$3.49M 0.02% 496
2020
Q4
$27.9M Buy
38,326
+12,324
+47% +$1.49M 0.01% 589
2020
Q3
$2.65M Sell
26,002
-12,420
-32% -$1.07M 0.01% 661
2020
Q2
$3.34M Buy
38,422
+18,392
+92% +$1.47M 0.01% 599
2020
Q1
$1.16M Buy
20,030
+7,116
+55% +$578K 0.01% 666
2019
Q4
$1.19M Buy
+12,914
New +$1.14M 0.01% 842

Other funds holding EXAS

KBC Group's EXAS Position: Q1 2026 in Review

KBC Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,155 shares — an estimated $930K sold.

KBC Group first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $40.2M in Q1 2022. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • KBC Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • KBC Group sold 9,155 Exact Sciences shares in Q1 2026, an estimated $930K.
  • KBC Group first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • KBC Group's Exact Sciences position peaked at $40.2M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.